A Transformable Nanoplatform Precisely Positions Fibroblast‐Like Synoviocytes via FAP‐α for Improved Rheumatoid Arthritis Therapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Chenglong Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sichuan Clinical Medical Research Center for Neurological Diseases, Deyang Key Laboratory of Tumor Molecular Research, Deyang…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synoviocytes, Fibroblasts, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Centrally Guided Local Science and Technology Development Project, Health Commission of Sichuan Province Medical Science and Technology Program.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation, damage, and disability. Activated fibroblast‐like synoviocytes (FLSs), abundant in RA synovium, crucially facilitate disease progression. These activated FLSs drive RA pathogenesis by upregulating adhesion molecules, proinflammatory cytokines, chemokines, and major histocompatibility complex class II (MHC‐II). This upregulation facilitates their interaction with CD4 + T cells, triggering an inflammatory cascade that exacerbates synovial inflammation. To address this, a DSPE‐mPEG 2000 ‐GPA‐KLVFF‐decorated liposome loaded with dexamethasone (DPGK@Lipo‐Dex) is developed to precisely target FLSs in arthritic joints. DPGK@Lipo‐Dex achieves efficient binding to FLSs through a specific enzymatic interaction between fibroblast activation protein‐α (FAP‐α) and GPA, along with prolonged retention in the joints due to the fibrillar transformation of KLVFF. In vitro studies demonstrate that DPGK@Lipo‐Dex enhances cellular uptake and reduces MHC‐II expression on aggressive FLSs. In adjuvant‐induced arthritis (AIA) rats, DPGK@Lipo shows specific distribution patterns that target both inflamed joints and FLSs. Treatment with DPGK@Lipo‐Dex leads to a downregulation of MHC‐II expression, a decrease in the number of activated T cells within the synovium, and a reduction in levels of proinflammatory mediators. Overall, DPGK@Lipo‐Dex effectively suppresses FLSs‐related responses and ultimately results in inflammatory remission. This makes DPGK@Lipo‐Dex a promising candidate for nano‐therapeutic treatment in rheumatoid arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Sichuan Clinical Medical Research Center for Neurological Diseases, Deyang Key Laboratory of Tumor Molecular Research, Deyang People's Hospital, Affiliated Hospital of Chengdu University of Tradi…
- Department of Stomatology, Deyang People's Hospital, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Deyang, 618000, China.
- Department of Pharmacy, Deyang People's Hospital, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Deyang, 618000, China.
- Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chen…
- State Key Laboratory of Southwestern Chinese Medicine Resources, College of Modern Chinese Medicine Industry, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
ORCID-Profile: Sanjun Shi
Förderung
- National Natural Science Foundation of China
- Centrally Guided Local Science and Technology Development Project
- Health Commission of Sichuan Province Medical Science and Technology Program
Zitieren
APA
Li, C., Xu, S., Li, X., Su, H., Qian, C., Hou, Y., & Shi, S. (2026). A Transformable Nanoplatform Precisely Positions Fibroblast‐Like Synoviocytes via FAP‐α for Improved Rheumatoid Arthritis Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503277
Vancouver
Li C, Xu S, Li X, Su H, Qian C, Hou Y, et al. A Transformable Nanoplatform Precisely Positions Fibroblast‐Like Synoviocytes via FAP‐α for Improved Rheumatoid Arthritis Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503277
BibTeX
@article{Li2026,
author = {Li, Chenglong and Xu, Shuhao and Li, Xin and Su, Huaiyu and Qian, Can and Hou, Yingying and Shi, Sanjun},
title = {A Transformable Nanoplatform Precisely Positions Fibroblast‐Like Synoviocytes via FAP‐α for Improved Rheumatoid Arthritis Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503277}
}
EUVIMED